And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather low-key. We hope to tend to some chores, hang with Mrs. Pharmalot and our short people, and observe a few more ancient rites. We may even take a nap. And what about you? This continues to be a lovely time of year to spend outdoors, so perhaps a drive to sunny shores or mountain peaks is in order. Conversely, you could stay close to home and curl up with a good book or watch a flick or two on the telly. Or maybe this is simply a good time to reflect on the world. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

Novartis (NVS) employees are bracing for a fresh wave of significant job cuts as part of a wider restructuring that could see more senior positions moved out of Switzerland, where the drug maker is headquartered, Swissinfo reports. As many as 800 jobs could be on the line between headquarters in Basel and a manufacturing plant in Stein, according  Basler Zeitung. Earlier this month, Novartis disclosed plans to increase profit margins by streamlining its production sites and administration worldwide.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy